Magazine
Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Psymposia
Magazine
Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Magazine
Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript
In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.
Magazine
Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript
In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.
Magazine
The Psychedelic Syndicate: Part 4
Part 4 of The Psychedelic Syndicate reveals PSFC’s strategy to manufacture spiritual and moral authority through academic capture — even as some members align with far-right ideologies that deepen the very crises psychedelics are meant to heal.
Magazine
The Psychedelic Syndicate: Part 3
Part 3 of The Psychedelic Syndicate exposes how Silicon Valley’s “move fast and break things” mentality infected psychedelic therapy, creating a culture where leaders rationalized patient harm as unavoidable for progress and ultimately embraced Trump administration officials who promised regulatory
Magazine
The Psychedelic Syndicate: Part 2
Part 2 of The Psychedelic Syndicate exposes the compromised foundation of PSFC’s influence network — from the abuse scandals that undermined their preferred therapy model, to undisclosed ties with the sole FDA advisory committee member who voted unequivocally for MDMA approval.
Magazine
The Psychedelic Syndicate: Part 1
Part 1 of The Psychedelic Syndicate reveals how the Psychedelic Science Funders Collaborative (PSFC) — a wealthy network of Silicon Valley elites and Burning Man devotees — systematically captured the psychedelic movement by influencing MAPS, funding its subsidiary Lykos’ MDMA clinical trials, and p
Magazine
Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia
Rather than unpacking the actual causes of Lykos Therapeutics’ disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.
Magazine
Correcting the Record: What The New York Times Got Wrong
In response to the The New York Times February 4 article, “How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy,” Psymposia requested corrections to numerous errors and false accusations.
Magazine
Psymposia’s Response to Heroic Hearts’ Pharma-Backed Press Conference
Veterans deserve the highest quality treatment for PTSD. It’s unacceptable and dangerous to use veterans as guinea pigs for a big pharma profit grab without resolving safety and efficacy concerns.
Magazine
A Resource for Journalists Covering Sexual Assault in Psychedelic Therapy
Language used by mainstream media affects the way we think about and respond to sexual violence, and no language is neutral. When journalists repeat the misrepresentations of abusers without qualification, they retraumatize victims and perpetuate ongoing misogynistic views about sexual violence.